Top

Published in:

01-01-2012 | Review article

Vitamin D and mammographic breast density: a systematic review

Authors: Lusine Yaghjyan, Graham A. Colditz, Bettina Drake

Published in: Cancer Causes & Control | Issue 1/2012

Abstract

Studies suggest a protective relationship between Vitamin D and breast cancer risk. Several studies assessed the association of Vitamin D with mammographic breast density, a known and strong breast cancer risk factor. Understanding the potential role of Vitamin D in the modification of breast density might open new avenues in breast cancer prevention. This systematic review summarizes published studies that investigated the association between Vitamin D and mammographic breast density and offers suggestions for strategies to advance our scientific knowledge.

Available only for authorised users

Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6(10):798–808PubMedCrossRef

Ginsburg OM, Martin LJ, Boyd NF (2008) Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 99(9):1369–1374PubMedCrossRef

Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99(15):1178–1187PubMedCrossRef

Harvey JA, Bovbjerg VE (2004) Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 230(1):29–41PubMedCrossRef

Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87(9):670–675PubMedCrossRef

Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87(21):1622–1629PubMedCrossRef

Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227–236PubMedCrossRef

Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14(2):343–349PubMedCrossRef

Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285(2):171–176PubMedCrossRef

10.

Vachon CM, Pankratz VS, Scott CG, Maloney SD, Ghosh K, Brandt KR, Milanese T, Carston MJ, Sellers TA (2007) Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(5):921–928PubMedCrossRef

11.

Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC (1994) Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 86(6):431–436PubMedCrossRef

12.

Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H (2010) Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121(2):469–477PubMedCrossRef

13.

Khan QJ, Kimler BF, Fabian CJ (2010) The relationship between vitamin D and breast cancer incidence and natural history. Curr Oncol Rep 12(2):136–142PubMedCrossRef

14.

Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R (2007) Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 16(3):422–429PubMedCrossRef

15.

Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC (2002) Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst 94(17):1301–1311PubMed

16.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2010) Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 46(12):2196–2205PubMedCrossRef

17.

IARC (2008) Vitamin D and cancer. France

18.

Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16(2):83–95PubMedCrossRef

19.

Cui Y, Rohan TE (2006) Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 15(8):1427–1437PubMedCrossRef

20.

Chouvet C, Vicard E, Devonec M, Saez S (1986) 1, 25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 24(1):373–376PubMedCrossRef

21.

Simboli-Campbell M, Narvaez CJ, Tenniswood M, Welsh J (1996) 1, 25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 58(4):367–376PubMedCrossRef

22.

Narvaez CJ, Zinser G, Welsh J (2001) Functions of 1alpha, 25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer. Steroids 66(3–5):301–308PubMedCrossRef

23.

Xue L, Lipkin M, Newmark H, Wang J (1999) Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice. J Natl Cancer Inst 91(2):176–181PubMedCrossRef

24.

Colston KW, Hansen CM (2002) Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 9(1):45–59PubMedCrossRef

25.

Banerjee P, Chatterjee M (2003) Antiproliferative role of vitamin D and its analogs–a brief overview. Mol Cell Biochem 253(1–2):247–254PubMedCrossRef

26.

Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7(9):684–700PubMedCrossRef

27.

Welsh J (2004) Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 80(6 Suppl):1721S–1724SPubMed

28.

Krishnan AV, Swami S, Feldman D (2010) Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol 121(1–2):343–348PubMedCrossRef

29.

Pattarozzi A, Gatti M, Barbieri F, Wurth R, Porcile C, Lunardi G, Ratto A, Favoni R, Bajetto A, Ferrari A, Florio T (2008) 17-beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment. Mol Pharmacol 73(1):191–202PubMedCrossRef

30.

LaMarca HL, Rosen JM (2007) Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage. Breast Cancer Res 9(4):304PubMedCrossRef

31.

Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH (2006) 17-beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 20(10):1622–1634PubMedCrossRef

32.

Seeger H, Deuringer FU, Wallwiener D, Mueck AO (2004) Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation. Maturitas 49(3):235–240PubMedCrossRef

33.

Johansson CM, Anderson TJ, Bergstrom R, Lindgren A, IR P (1998) Epithelial proliferation in the normal human breast in relation to endogenous hormones and oral contraceptive use. The Breast 7:162–167CrossRef

34.

Sutherland RL, Prall OW, Watts CK, Musgrove EA (1998) Estrogen and progestin regulation of cell cycle progression. J Mammary Gland Biol Neoplasia 3(1):63–72PubMedCrossRef

35.

Foidart JM, Colin C, Denoo X, Desreux J, Beliard A, Fournier S, de Lignieres B (1998) Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril 69(5):963–969PubMedCrossRef

36.

Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15(1):17–35PubMed

37.

Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21(3):427–433PubMedCrossRef

38.

Zhu BTCA (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1–27PubMedCrossRef

39.

Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F (2010) Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 10:483PubMedCrossRef

40.

Tseng M, Byrne C, Evers KA, Daly MB (2007) Dietary intake and breast density in high-risk women: a cross-sectional study. Breast Cancer Res 9(5):R72PubMedCrossRef

41.

Laird NM, Mosteller F (1990) Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6(1):5–30PubMedCrossRef

42.

Diorio C, Berube S, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, Cote G, Pollak M, Brisson J (2006) Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density. Cancer Res 66(1):588–597PubMedCrossRef

43.

Tworoger S, Hankinson S (2006) Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control 17(7):889–899PubMedCrossRef

44.

Jeffreys M, Warren R, Smith GD, Gunnell D (2003) Breast density: agreement of measures from film and digital image. Br J Radiol 76(908):561–563PubMedCrossRef

45.

Lee-Han H, Cooke G, Boyd NF (1995) Quantitative evaluation of mammographic densities: a comparison of methods of assessment. Eur J Cancer Prev 4(4):285–292PubMedCrossRef

46.

Muhimmah I, Zwiggelaar R (2006) Mammographic density classification using multiresolution histogram information. In: The international special topic conference on information technology in biomedicine (ITAB’06). Ioannina, Greece

47.

Colangelo LA, Chiu BCH, Lopez P, Scholtens D, Willis LC, Hendrick RE, Gapstur SM (2006) A pilot study of vitamin D, calcium, and percent breast density in Hispanic women. Nutrition Research 26(1):11–15CrossRef

48.

Thomson CA, Arendell LA, Bruhn RL, Maskarinec G, Lopez AM, Wright NC, Moll CE, Aickin M, Chen Z (2007) Pilot study of dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic white women. Menopause 14(2):243–250PubMedCrossRef

49.

Berube S, Diorio C, Masse B, Hebert-Croteau N, Byrne C, Cote G, Pollak M, Yaffe M, Brisson J (2005) Vitamin D and calcium intakes from food or supplements and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14(7):1653–1659PubMedCrossRef

50.

Brisson J, Berube S, Diorio C, Sinotte M, Pollak M, Masse B (2007) Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin d. Cancer Epidemiol Biomarkers Prev 16(5):929–933PubMedCrossRef

51.

Bertone-Johnson ER, Chlebowski RT, Manson JE, Wactawski-Wende J, Aragaki AK, Tamimi RM, Rexrode KM, Thomson CA, Rohan TE, Peck JD, Pisano ED, Martin CF, Sarto G, McTiernan A (2010) Dietary vitamin D and calcium intake and mammographic density in postmenopausal women. Menopause 17(6):1152–1160PubMedCrossRef

52.

Knight JA, Vachon CM, Vierkant RA, Vieth R, Cerhan JR, Sellers TA (2006) No association between 25-hydroxyvitamin D and mammographic density. Cancer Epidemiol Biomarkers Prev 15(10):1988–1992PubMedCrossRef

53.

Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 9(2):151–160PubMed

54.

Green AK, Hankinson SE, Bertone-Johnson ER, Tamimi RM (2010) Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women. Int J Cancer 127(3):667–674PubMedCrossRef

55.

Masala G, Ambrogetti D, Assedi M, Giorgi D, Del Turco MR, Palli D (2006) Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer 118(7):1782–1789PubMedCrossRef

56.

Mishra G, McCormack V, Kuh D, Hardy R, Stephen A, dos Santos Silva I (2008) Dietary calcium and vitamin D intakes in childhood and throughout adulthood and mammographic density in a British birth cohort. Br J Cancer 99(9):1539–1543PubMedCrossRef

57.

Neuhouser ML, Bernstein L, Hollis BW, Xiao L, Ambs A, Baumgartner K, Baumgartner R, McTiernan A, Ballard-Barbash R (2010) Serum vitamin D and breast density in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 19(2):412–417PubMedCrossRef

58.

Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg CL, Wactawski-Wende J, Rohan T, O’Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA (2011) 25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women. Maturitas 68(1):73–78PubMedCrossRef

59.

Wu H, Gozdzik A, Barta JL, Wagner D, Cole DE, Vieth R, Parra EJ, Whiting SJ (2009) The development and evaluation of a food frequency questionnaire used in assessing vitamin D intake in a sample of healthy young Canadian adults of diverse ancestry. Nutr Res 29(4):255–261PubMedCrossRef

60.

Signorello LB, Williams SM, Zheng W, Smith JR, Long J, Cai Q, Hargreaves MK, Hollis BW, Blot WJ (2010) Blood Vitamin D Levels in Relation to Genetic Estimation of African Ancestry. Cancer Epidemiol Biomarkers Prev 19(9):2325–2331PubMedCrossRef

61.

Sinotte M, Diorio C, Berube S, Pollak M, Brisson J (2009) Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 89(2):634–640PubMedCrossRef

62.

D’Alésio A, Garabédian M, Sabatier JP, Guaydier-Souquières G, Marcelli C, Lemaçon A, Walrant-Debray O, Jehan F (2005) Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein–DNA complex formation and are associated with height and vitamin D status in adolescent girls. Hum Mol Genet 14(22):3539–3548PubMedCrossRef

63.

Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J, Kelly P (1995) Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab 80(9):2800–2805PubMedCrossRef

64.

Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP (2010) Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 19(4):927–931PubMedCrossRef

65.

Higashi T, Shimada K, Toyo’oka T (2010) Advances in determination of vitamin D related compounds in biological samples using liquid chromatography-mass spectrometry: a review. J Chromatogr B Analyt Technol Biomed Life Sci 878(20):1654–1661PubMedCrossRef

66.

Chai W, Maskarinec G, Cooney RV (2010) Serum 25-hydroxyvitamin D levels and mammographic density among premenopausal women in a multiethnic population. Eur J Clin Nutr 64(6):652–654PubMedCrossRef

67.

Kerlikowske K, Cook AJ, Buist DS, Cummings SR, Vachon C, Vacek P, Miglioretti DL (2010) Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol 28(24):3830–3837PubMedCrossRef

68.

Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, Scott CG, Radisky DC, Sellers TA, Pankratz VS, Vachon CM (2010) Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 28(13):2207–2212PubMedCrossRef

69.

Munir J, Birge S (2008) Vitamin D Deficiency in Pre and Postmenopausal Women. Menopause Management 17(5):10–21

70.

Duque G, El Abdaimi K, Macoritto M, Miller MM, Kremer R (2002) Estrogens (E2) regulate expression and response of 1, 25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation. Biochem Biophys Res Commun 299(3):446–454PubMedCrossRef

71.

Talley LI, Grizzle WE, Waterbor JW, Brown D, Weiss H, Frost AR (2002) Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women. Int J Cancer 98(1):118–127PubMedCrossRef

72.

Misell L, Hwang E, Au A, Esserman L, Hellerstein M (2005) Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans. Breast Cancer Res Treat 89(3):257–264PubMedCrossRef

73.

Guillemette C, Belanger A, Lepine J (2004) Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res 6(6):246–254PubMedCrossRef

74.

Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344(4):276–285PubMedCrossRef

75.

Ursin G, Parisky YR, Pike MC, Spicer DV (2001) Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 10(2):141–142PubMed

76.

White E, Velentgas P, Mandelson MT, Lehman CD, Elmore JG, Porter P, Yasui Y, Taplin SH (1998) Variation in mammographic breast density by time in menstrual cycle among women aged 40–49 Years. J Natl Cancer Inst 90(12):906–910PubMedCrossRef

77.

Berube S, Diorio C, Brisson J (2008) Multivitamin-multimineral supplement use and mammographic breast density. Am J Clin Nutr 87(5):1400–1404PubMed

Title: Vitamin D and mammographic breast density: a systematic review
Authors: Lusine Yaghjyan
Graham A. Colditz
Bettina Drake
Publication date: 01-01-2012
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 1/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-011-9851-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2012

Why mammography screening has not lived up to expectations from the randomised trials

Bodyweight and other correlates of symptom-detected breast cancers in a population offered screening

Factors associated with mortality after breast cancer metastasis

Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium

Factors that influence mammography use and breast cancer detection among Mexican-American and African-American women

Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer